期刊文献+

HPLC法同时测定琥珀酸曲格列汀中9个杂质的含量 被引量:1

Simultaneous Determination of Nine Impurities in Tragaliptin Succinate by HPLC
下载PDF
导出
摘要 目的:建立高效液相色谱法同时测定琥珀酸曲格列汀中9个杂质的含量。方法:采用Welch Utimate AQ C18(4.6 mm×250 mm,5μm)色谱柱,以0.1%磷酸溶液-乙腈为流动相,梯度洗脱,流速1.0 mL·min^(-1),柱温35℃,检测波长230 nm。结果:该药与已知杂质Ⅰ~Ⅸ色谱峰之间的分离度良好;该药和已知杂质Ⅰ~Ⅸ分别在各自的线性范围内线性关系均良好(r^(2)≥0.9999),杂质Ⅰ~Ⅸ的校正因子分别为1.3、0.9、0.5、1.2、1.2、1.0、2.1、2.3、1.0,且该药和已知杂质Ⅰ~Ⅸ的平均回收率均在99.0%~101.0%。结论:该方法专属性强,重复性好,可用于测定该药中的有关物质。 Objective:To establish an HPLC method for simultaneous determination of 9 impurities in tragaliptin succinate.Methods:The analysis was performed by HPLC with a Welch Utimate AQ C18 column(4.6 mm×250 mm,5μm),the mobile phase was an acetonitrile-0.1%phosphoric acid aqueous solution gradiently eluted at 1.0 mL·min^(-1),the column temperature was 35℃and the detection wavelength was 230 nm.Results:The resolutions between the peaks of tragaliptin succinate and nine known impuritiesⅠ-Ⅸwere good.Tragaliptin succinate and the known impuritiesⅠ-Ⅸhad good linear relationships in their respective linear ranges(r2≥0.999)with average recoveries at 99.0%-101.0%,the correction factors for the impuritiesⅠ-Ⅸwere 1.3,0.9,0.5,1.2,1.2,1.0,2.1,2.3 and 1.0.Conclusion:This method is specific and accurate,and can be used to detect related substances in tragaliptin succinate.
作者 李尚 徐佳雯 张斐 LI Shang;XU Jiawen;ZHANG Fei(New Drug Research and Clinical Pharmacy Key Laboratory,Xuzhou Medical University,Xuzhou 221000,China;Jiangsu Fspharm Biotech Ltd.,Nanjing 210033,China)
出处 《药学与临床研究》 2021年第2期92-96,共5页 Pharmaceutical and Clinical Research
关键词 琥珀酸曲格列汀 高效液相色谱 校正因子 有关物质 Tragaliptin succinate HPLC Correction factor Related substances
  • 相关文献

参考文献3

二级参考文献4

  • 1New Drug Application Approval of Zafatek Tablets for the treatment of Type 2 Diabetes in Japan[OL].http://www.takeda.com/news/2015/20150326_6953.html.
  • 2Merck Submits New Drug Application to the Japanese Pharmaceuticals and Medical Devices Agency for Omarigliptin,an Investigational Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes[OL].http://www.mercknewsroom.com/news-release/prescription-medicine-news/merck-submits-newdrug-application-japanese-pharmaceuticals-.
  • 3西格列汀心血管安全性获肯定[OL].http://www.msdchina.com.cn/newsroom/Pages/product-news_2015_04_27.aspx.
  • 4中国2型糖尿病防治指南(2013年版)[J].中华糖尿病杂志,2014,6(7):447-498. 被引量:1300

共引文献14

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部